2,3-Dihydroxybenzoic acid. Effect on mortality rate in a septic rat model

Area of Science:

• Biomedical Science
• Pharmacology
• Sepsis Research

Background:

• Neutrophil-derived oxygen-free radicals are implicated in sepsis-induced organ dysfunction.
• Free radical scavengers like DMSO and 2,3-DHB are potential therapeutic agents.
• 2,3-DHB possesses iron-chelating properties, suggesting possible bacteriostatic effects.

Purpose of the Study:

• To evaluate the efficacy of dimethyl sulfoxide (DMSO) and 2,3-dihydroxybenzoic acid (2,3-DHB) in reducing mortality in a rat model of intra-abdominal sepsis.
• To assess the individual and combined effects of these scavengers with gentamicin sulfate.

Main Methods:

• A rat model of intra-abdominal sepsis was induced via cecal ligation and perforation.
• Rats received treatments including no treatment, gentamicin alone, DMSO alone, 2,3-DHB alone, and combinations of gentamicin with DMSO or 2,3-DHB.
• Survival rates were statistically analyzed to determine treatment efficacy.

Main Results:

• No significant survival improvement was observed with gentamicin alone, DMSO alone, or 2,3-DHB alone.
• The combination of gentamicin with DMSO did not yield a statistically significant increase in survival.
• A statistically significant improvement in survival was achieved when 2,3-DHB was administered in combination with gentamicin.

Conclusions:

• Dimethyl sulfoxide (DMSO) alone or in combination with gentamicin does not improve survival in this sepsis model.
• 2,3-dihydroxybenzoic acid (2,3-DHB), particularly when combined with gentamicin, demonstrates a beneficial effect on mortality in intra-abdominal sepsis.
• The combination therapy of 2,3-DHB and gentamicin shows promise for managing intra-abdominal sepsis.